MSF denied access to Gilead HIV-prevention drug
EU Reporter —
A dispute between Médecins Sans Frontières (MSF) and Gilead Sciences has entered the public domain after the pharma company refused to sell its game-changing HIV-prevention medicine despite multiple requests. Lenacapavir, a twice-yearly injectable form of PrEP, could be a game changer, especially for people who struggle to access daily medication. In an open letter Chief […]